{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:14:42Z","timestamp":1772889282526,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005290","name":"SCUN","doi-asserted-by":"publisher","award":["YCZY12019"],"award-info":[{"award-number":["YCZY12019"]}],"id":[{"id":"10.13039\/501100005290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejphar.2018.07.025","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T12:13:14Z","timestamp":1532607194000},"page":"206-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Characterization and molecular basis for the block of Kv1.3 channels induced by carvedilol in HEK293 cells"],"prefix":"10.1016","volume":"834","author":[{"given":"Jin-Feng","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.07.025_bib1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4253\/wjge.v7.i5.532","article-title":"Is it time to replace propranolol with carvedilol for portal hypertension?","volume":"7","author":"Abid","year":"2015","journal-title":"World J. Gastrointest. Endosc."},{"key":"10.1016\/j.ejphar.2018.07.025_bib2","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0022-3565(24)39002-0","article-title":"Effects of carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress","volume":"295","author":"Abreu","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.07.025_bib3","first-page":"281","article-title":"Mammalian osteoclasts express a transient potassium channel with properties of Kv1.3","volume":"2","author":"Arkett","year":"1994","journal-title":"Recept. Channels"},{"key":"10.1016\/j.ejphar.2018.07.025_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1085\/jgp.58.4.413","article-title":"Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons","volume":"58","author":"Armstrong","year":"1971","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ejphar.2018.07.025_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/cvr\/cvp284","article-title":"Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner","volume":"85","author":"Barana","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2018.07.025_bib6","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0605136103","article-title":"Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases","volume":"103","author":"Beeton","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2018.07.025_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-065X.2009.00816.x","article-title":"The functional network of ion channels in T lymphocytes","volume":"231","author":"Cahalan","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2018.07.025_bib8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0896-6273(00)80403-1","article-title":"Characterizing voltage-dependent conformational changes in the Shaker K+ channel with fluorescence","volume":"19","author":"Cha","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2018.07.025_bib9","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1074\/jbc.M112.343996","article-title":"Hg1, novel peptide inhibitor specific for Kv1.3 channels from first scorpion Kunitz-type potassium channel toxin family","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.07.025_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-2999(99)00368-4","article-title":"Carvedilol blocks the repolarizing K+ currents and the L-type Ca2+ current in rabbit ventricular myocytes","volume":"376","author":"Cheng","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.07.025_bib11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/aps.2010.133","article-title":"Kv1.3: a potential pharmacological target for diabetes","volume":"31","author":"Choi","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2018.07.025_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1471-4159.1999.0730849.x","article-title":"Subunit composition of Kv1 channels in human CNS","volume":"73","author":"Coleman","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2018.07.025_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.lfs.2006.10.012","article-title":"Effects of carvedilol on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes","volume":"80","author":"Deng","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2018.07.025_bib14","doi-asserted-by":"crossref","first-page":"10036","DOI":"10.1073\/pnas.90.21.10036","article-title":"Heterologous expression of specific K+ channels in T lymphocytes: functional consequences for volume regulation","volume":"90","author":"Deutsch","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2018.07.025_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00003495-199754010-00015","article-title":"Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders","volume":"54","author":"Dunn","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2018.07.025_bib16","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1111\/bph.13283","article-title":"State-dependent blocking mechanism of Kv 1.3 channels by the antimycobacterial drug clofazimine","volume":"172","author":"Faouzi","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.07.025_bib17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.RES.73.1.210","article-title":"Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current","volume":"73","author":"Fedida","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2018.07.025_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1476-5381.2009.00539.x","article-title":"Mechanisms of Kv2.1 channel inhibition by celecoxib--modification of gating and channel block","volume":"159","author":"Frolov","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.07.025_bib19","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.bbabio.2010.01.018","article-title":"Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes","volume":"1797","author":"Gulbins","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2018.07.025_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bcp.2011.11.019","article-title":"Carvedilol blocks the cloned cardiac Kv1.5 channels in a beta-adrenergic receptor-independent manner","volume":"83","author":"Jeong","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.07.025_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0008-6363(00)00265-0","article-title":"Antiarrhythmic drug carvedilol inhibits HERG potassium channels","volume":"49","author":"Karle","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2018.07.025_bib22","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjp.0706508","article-title":"Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy","volume":"147","author":"Kawakami","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.07.025_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0006-3495(99)77194-8","article-title":"Contribution of the selectivity filter to inactivation in potassium channels","volume":"76","author":"Kiss","year":"1999","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2018.07.025_bib24","doi-asserted-by":"crossref","first-page":"27577","DOI":"10.1074\/jbc.272.44.27577","article-title":"Complex subunit assembly of neuronal voltage-gated K+ channels. Basis for high-affinity toxin interactions and pharmacology","volume":"272","author":"Koch","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.07.025_bib25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1476-5381.2009.00202.x","article-title":"Effect of K+ and Rb+ on the action of verapamil on a voltage-gated K+ channel, hKv1.3: implications for a second open state?","volume":"157","author":"Kuras","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.07.025_bib26","doi-asserted-by":"crossref","first-page":"e0124602","DOI":"10.1371\/journal.pone.0124602","article-title":"The Inhibitory Effects of Ca2+ Channel Blocker Nifedipine on Rat Kv2.1 Potassium Channels","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2018.07.025_bib27","doi-asserted-by":"crossref","first-page":"H1160","DOI":"10.1152\/ajpheart.2001.280.3.H1160","article-title":"Influence of permeating ions on Kv1.5 channel block by nifedipine","volume":"280","author":"Lin","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2018.07.025_bib28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.RES.72.3.671","article-title":"Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle","volume":"72","author":"Liu","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2018.07.025_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1084\/jem.20020381","article-title":"Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation","volume":"196","author":"Liu","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2018.07.025_bib30","first-page":"61","article-title":"Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels","volume":"1","author":"Lopez-Barneo","year":"1993","journal-title":"Recept. Channels"},{"key":"10.1016\/j.ejphar.2018.07.025_bib31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2165\/00003495-199345020-00006","article-title":"Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy","volume":"45","author":"McTavish","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2018.07.025_bib32","first-page":"709","article-title":"Pharmacokinetics of carvedilol in older and younger patients","volume":"4","author":"Morgan","year":"1990","journal-title":"J. Hum. Hypertens."},{"issue":"Suppl 11","key":"10.1016\/j.ejphar.2018.07.025_bib33","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/00005344-198710004-00015","article-title":"Pharmacokinetics and disposition of carvedilol in humans","volume":"10","author":"Neugebauer","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.07.025_bib34","doi-asserted-by":"crossref","first-page":"C27","DOI":"10.1152\/ajpcell.00136.2017","article-title":"The secret life of ion channels: Kv1.3 potassium channels and proliferation","volume":"314","author":"Perez-Garcia","year":"2018","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2018.07.025_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1007735729121","article-title":"Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure","volume":"11","author":"Ruffolo","year":"1997","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2018.07.025_bib36","doi-asserted-by":"crossref","first-page":"11094","DOI":"10.1073\/pnas.0501770102","article-title":"The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain","volume":"102","author":"Rus","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2018.07.025_bib37","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/00004647-200008000-00005","article-title":"The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke","volume":"20","author":"Savitz","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2018.07.025_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bbrc.1993.1203","article-title":"Immunological identification of the Shaker-related Kv1.3 potassium channel protein in T and B lymphocytes, and detection of related proteins in files and yeast","volume":"191","author":"Spencer","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2018.07.025_bib39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.17219\/acem\/22339","article-title":"Voltage-gated potassium channels Kv1.3--potentially new molecular target in cancer diagnostics and therapy","volume":"24","author":"Teisseyre","year":"2015","journal-title":"Adv. Clin. Exp. Med."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2018.07.025_bib40","first-page":"S27","article-title":"Clinical pharmacology of carvedilol","volume":"70","author":"Tomlinson","year":"1992","journal-title":"Clin. Investig."},{"key":"10.1016\/j.ejphar.2018.07.025_bib41","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.celrep.2016.08.016","article-title":"Decrease of a current mediated by Kv1.3 channels causes striatal cholinergic interneuron hyperexcitability in experimental Parkinsonism","volume":"16","author":"Tubert","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2018.07.025_bib42","doi-asserted-by":"crossref","first-page":"37675","DOI":"10.1074\/jbc.M605617200","article-title":"Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages","volume":"281","author":"Vicente","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.07.025_bib43","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nrd2983","article-title":"Voltage-gated potassium channels as therapeutic targets","volume":"8","author":"Wulff","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2018.07.025_bib44","doi-asserted-by":"crossref","first-page":"32040","DOI":"10.1074\/jbc.M105231200","article-title":"Delineation of the clotrimazole\/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1","volume":"276","author":"Wulff","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.07.025_bib45","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4049\/jimmunol.173.2.776","article-title":"K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity","volume":"173","author":"Wulff","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2018.07.025_bib46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-3565(25)10363-7","article-title":"Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger","volume":"263","author":"Yue","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.07.025_bib47","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0022-3565(24)36723-0","article-title":"Characterization of nifedipine block of the human heart delayed rectifier, hKv1.5","volume":"281","author":"Zhang","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.07.025_bib48","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.4049\/jimmunol.0803003","article-title":"Developmental switch of the expression of ion channels in human dendritic cells","volume":"183","author":"Zsiros","year":"2009","journal-title":"J. Immunol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918303935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918303935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T01:43:37Z","timestamp":1751766217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918303935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":48,"alternative-id":["S0014299918303935"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.025","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization and molecular basis for the block of Kv1.3 channels induced by carvedilol in HEK293 cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}